IP Library Granted Patent US 7,141,045
Granted Patent B2
US 7,141,045 · App. 10/265,174 · Granted Nov 28, 2006

Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,141,045
App. No.
10/265,174
Granted
Nov 28, 2006
Kind
B2
Abstract

Methods of enhancing fluid flow through a vascular site occupied by a vascular occlusion, as well as systems and kits for use in practicing the same, are provided. In practicing the subject methods, the vascular site is flushed simultaneously with a first dissolution fluid (e.g., an organic matter dissolution fluid and/or an inorganic matter dissolution fluid), and a second dissolution fluid attenuating fluid, where flushing is carried out in a manner such that only a surface of the vascular occlusion is contacted with the non-attenuated dissolution fluid. The subject methods, systems and kits for practicing the same find use in the treatment of a variety of different vascular diseases characterized by the presence of vascular occlusions, including both partial and total occlusions.

Claims (47)

1. A method of enhancing fluid flow through a vascular site occupied by an organic matter comprising vascular occlusion, said method comprising:

simultaneously flushing said vascular site with:

(i) an organic matter dissolution fluid; and

(ii) an organic matter dissolution fluid attenuating fluid;

for a period of time sufficient for fluid flow to be enhanced through said vascular site;

with the proviso that said simultaneous flushing occurs in a manner such that only a surface of said organic matter comprising vascular occlusion is contacted with non-attenuated organic matter dissolution fluid and the remainder of said vascular site is not contacted with non-attenuated organic matter dissolution fluid;

whereby fluid flow is enhanced through said vascular site.

2. The method according to claim 1 , wherein said organic matter dissolution fluid comprises an active agent selected from the group consisting of enzymes, surfactants, oxidizing and thrombolytic agents.

3. The method according to claim 1 , wherein said organic matter dissolution fluid attenuating agent is an aqueous fluid.

4. The method according to claim 1 , wherein said organic matter dissolution fluid comprises an oxidizing agent.

5. The method according to claim 4 , wherein said organic matter dissolution fluid attenuating agent comprises an aqueous buffer solution.

6. The method according to claim 5 , wherein said wherein said organic matter dissolution fluid comprises surfactant.

7. The method according to claim 1 , wherein said vascular occlusion is a total occlusion.

8. The method according to claim 1 , wherein said vascular occlusion is a partial occlusion.

9. A method of enhancing fluid flow through a vascular site occupied by an inorganic matter comprising vascular occlusion, said method comprising:

simultaneously flushing said vascular site with:

(i) an inorganic matter dissolution fluid; and

(ii) an inorganic matter dissolution fluid attenuating fluid;

for a period of time sufficient for fluid flow to be enhanced through said vascular site;

with the proviso that said simultaneous flushing occurs in a manner such that only a surface of said inorganic matter comprising vascular occlusion is contacted with non-attenuated inorganic matter dissolution fluid and the remainder of said vascular site is not contacted with non-attenuated inorganic matter dissolution fluid;

whereby fluid flow is enhanced through said vascular site.

10. The method according to claim 9 , wherein said inorganic matter is a calcium phosphate mineral.

11. The method according to claim 9 , wherein said inorganic matter dissolution fluid is an acidic solution.

12. The method according to claim 11 , wherein said inorganic matter dissolution fluid attenuating fluid is a buffer solution.

13. The method according to claim 9 , wherein said vascular occlusion is a total occlusion.

14. The method according to claim 9 , wherein said vascular occlusion is a partial occlusion.

15. A method of enhancing fluid flow through a vascular site occupied by vascular occlusion, said method comprising:

simultaneously flushing said vascular site with:

(i) a dissolution fluid that dissolves both organic and inorganic matter; and

(ii) a dissolution fluid attenuating fluid;

for a period of time sufficient for fluid flow to be enhanced through said vascular site;

with the proviso that said simultaneous flushing occurs in a manner such that only a surface of said inorganic matter comprising vascular occlusion is contacted with non-attenuated dissolution fluid and the remainder of said vascular site is not contacted with non-attenuated dissolution fluid;

whereby fluid flow is enhanced through said vascular site.

16. The method according to claim 15 , wherein said dissolution fluid comprises an acid.

17. The method according to claim 15 , wherein said dissolution fluid comprises a surfactant.

18. The method according to claim 15 , wherein said dissolution fluid attenuating fluid is a buffer solution.

19. The method according to claim 15 , wherein said vascular occlusion is a total occlusion.

20. The method according to claim 15 , wherein said vascular occlusion is a partial occlusion.

21. A lesion dissolution fluid comprising:

an acid; and

a surfactant.

22. The fluid according to claim 21 , wherein said fluid further comprises a salt.

23. The fluid according to claim 21 , wherein said acid is an inorganic acid.

24. The fluid according to claim 21 , wherein said inorganic acid is hydrogen chloride.

25. The fluid according to claim 21 , wherein said surfactant is selected from the group consisting of cationic surfactants, anionic surfactants, zwitterionic surfactants and nonionic surfactants.

26. The fluid according to claim 25 , wherein said surfactant is a cationic surfactant.

27. The fluid according to claim 26 , wherein said cationic surfactant is sodium dodecyl sulfate.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042126/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2008
From: CORAZON TECHNOLOGIES, INC.
To: CORDIS CORPORATION
Reel/Frame 020609/0277 →
RELEASE Recorded Dec 15, 2003
From: SILICON VALLEY BANK
To: CORAZON TECHNOLOGIES, INC.
Reel/Frame 014797/0206 →